Press-release for stocks for fnctf

Prices are updated after-hours

symbols : Fnctf

save search

SMX Introduces Advisory Board Appointments Following Nasdaq Listing
Published: 2023-03-14 (Crawled : 13:20) - prnewswire.com
SMX | $0.1693 2.54% 2.48% 610K

n/a

| -94.28% | O: 9.76% H: 22.39% C: 9.51%
MS | News | $90.66 0.44% 0.07% 8.1M

Finance

| 3.03% | O: 5.02% H: 0.0% C: -2.64%
nasdaq

Mobix Labs Aims To Go Public by Year's End – Orange County Business Journal
Published: 2023-11-20 (Crawled : 22:00) - spacfeed.com
HNRA P | $2.99 17.72% -9.7% 310K

n/a

| 80.13% | O: -3.21% H: 16.56% C: 11.26%
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -59.25% | O: 3.7% H: 0.0% C: 0.0%
business

Beyond the SPAC Hype
Published: 2023-09-03 (Crawled : 00:00) - spacfeed.com
FNCTF | News | $11.0354 -20.84% 320

Communications

| Email alert Add to watchlist
ORGN 4 | $0.68 16.94% 14.49% 2.8M

Mining, Quarrying, and Oil and ...

| Email alert Add to watchlist
FEXD | $11.05 0.27% 34

| Email alert Add to watchlist
beyond spac

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -5.89% | O: -0.27% H: 0.1% C: 0.1%
NTRB | $3.91 -3.22% -3.32% 26K

Manufacturing

| 11.97% | O: -2.85% H: 0.0% C: -1.76%
RANI | $6.86 13.39% 11.81% 200K

| 11.16% | O: -1.1% H: 1.91% C: -3.82%
MRK | News | $125.78 0.44% 0.0% 8.4M

Health Technology

| 14.47% | O: 0.11% H: 0.0% C: -1.35%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 12.42% | O: -1.02% H: 0.0% C: -0.86%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.22% | O: -0.72% H: 0.0% C: 0.0%
conference transdermal

Synthetic Dyes Market to Reach $11.5 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2023-11-10 (Crawled : 05:00) - prnewswire.com
VNTRF | $0.011 10.0% -9.09% 170K

n/a

| 214.29% | O: 0.0% H: 2.86% C: 0.0%
reach research market

MAIA Biotechnology to Present at AACR Annual Meeting 2023
Published: 2023-04-12 (Crawled : 13:00) - biospace.com/
MAIA | $2.15 9.69% 0.0% 100K

| -44.01% | O: 2.6% H: 0.0% C: -6.6%
FNCTF | News | $11.0354 -20.84% 320

Communications

| -11.0% | O: 1.53% H: 0.0% C: -0.71%
meeting

DZS and Orange Partner to Bring Advanced New Fiber Technologies and Services to Homes and Businesses
Published: 2023-10-17 (Crawled : 08:00) - globenewswire.com
DZSI M | $1.17 9.35% 8.55% 100K

Electronic Technology

| -35.8% | O: -1.7% H: 5.78% C: 5.2%
services homes

DZS Announces Two New Board of Director Members
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
DZSI M | $1.17 9.35% 8.55% 100K

Electronic Technology

| -16.91% | O: -2.21% H: 18.05% C: 12.78%

Village Farms Supports Hope for the Holidays
Published: 2022-12-07 (Crawled : 19:00) - villagefarms.com
FNCTF | News | $11.0354 -20.84% 320

Communications

| 12.43% | O: -0.76% H: 0.0% C: 0.0%
VFF | $1.34 8.94% 8.21% 610K

Process Industries

| -24.43% | O: 0.57% H: 1.69% C: -1.69%
farms

BioXcel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights
Published: 2023-03-09 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320

Communications

| -1.07% | O: 1.93% H: 0.0% C: 0.0%
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -90.3% | O: -5.08% H: 5.81% C: -8.77%
year therapeutics financial results

BioXcel Therapeutics Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI™ (dexmedetomidine) Sublingual Film
Published: 2023-10-04 (Crawled : 11:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| 17.52% | O: -2.56% H: 35.96% C: 16.23%
update expansion therapeutics

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -50.09% | O: -35.39% H: 19.38% C: 18.54%
fda update trial therapeutics financial results

BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
Published: 2024-03-12 (Crawled : 11:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -5.17% | O: 13.79% H: 0.0% C: -16.06%
year therapeutics financial results

BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine
Published: 2024-02-05 (Crawled : 12:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -10.13% | O: 9.48% H: 15.37% C: 10.75%
patent disease alzheimer’s application therapeutics

BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
Published: 2024-03-15 (Crawled : 11:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -4.18% | O: -1.74% H: 2.13% C: -4.96%
patent grant therapeutics

BM Technologies Honors 2021 ACE Award and Partnership Winners
Published: 2021-12-14 (Crawled : 14:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320

Communications

| 7.14% | O: 1.65% H: 0.0% C: -1.39%
BMTX 4 | $1.585 8.56% -2.21% 3.2K

Information

| -83.33% | O: -0.72% H: 4.79% C: 3.19%
FRBA | $12.66 4.46% 4.27% 57K

Finance

| -10.17% | O: 1.98% H: 2.63% C: 0.21%
partnership awards

Draganfly to Speak at Law-Tech Connect™ Workshop During AUVSI XPONENTIAL 2022
Published: 2022-04-21 (Crawled : 16:00) - draganfly.com
DPRO | $0.2565 7.59% 9.35% 1.4M

| -83.73% | O: -1.33% H: 0.0% C: 0.0%

RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034
Published: 2021-10-12 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320

Communications

| 2.65% | O: 1.86% H: 0.0% C: 0.0%
RDHL | $0.4519 7.39% 6.88% 330K

Health Technology

| -90.53% | O: -0.84% H: 1.91% C: -0.42%
biopharma patent injection infections

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320

Communications

| 1.99% | O: -3.6% H: 0.0% C: -0.77%
RDHL | $0.4519 7.39% 6.88% 330K

Health Technology

| -84.95% | O: -7.19% H: 0.0% C: 0.0%
NKTR | News | $1.265 -4.17% -4.35% 4.7M

Health Technology

| -89.22% | O: -2.3% H: 0.0% C: 0.0%
biopharma financial results results

RedHill Presents New Talicia® Data Analyses at Obesity Week 2022
Published: 2022-11-04 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320

Communications